Baseline Characteristics of the Participants Who Received at Least 1 Dose of the Assigned Treatment
obesity, chronic kidney disease, malignancy, cancer, asthma, type 2 diabetes
OBESITY, UNCONTROLLED HYPERTENSION, ISCHEMIC HEART DISEASE, CANCER, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, TYPE 2 DIABETES, DISEASES, CHRONIC LIVER DISEASE
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); IgG, immunoglobulin G.Underlying diseases: obesity (BMI >30), controlled hypertension, chronic kidney disease, chronic liver disease, type 2 diabetes, chronic obstructive pulmonary disease), controlled asthma, history of any malignancy or cancer, and ischemic heart disease. The details are provided in the protocol (Supplement 1).IgG antibodies against the S1 subunit (S1 IgG).